Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Capricor Therapeutics is a U.S. biotechnology company focused on the development of novel cell and exosome-based therapies. The company specializes in regenerative medicine for rare diseases, such as Duchenne muscular dystrophy, while advancing innovative biotechnological solutions for patients.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Capricor Therapeutics is scheduled to report its next quarterly earnings on 11/17/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Capricor Therapeutics last reported quarterly earnings on 8/13/2026 (Q2 2026). Earnings per share (EPS) came in at -0.70 USD.
Across its last 3 earnings reports, Capricor Therapeutics stock moved by ±23.5% on average the following day. The largest reaction was +58% on 08/13/2026; 1 of 3 reactions were positive.
Capricor Therapeutics has beaten analyst EPS estimates in 0 of its last 3 evaluated quarters (beat rate: 0%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 3 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.